(1,3)-ß-D-glucan synthesis inhibitor | |
---|---|
Trade Name | |
Orphan Indication | Invasive Aspergillus infections |
USA Market Approval | USA |
USA Designation Date | 2016-08-22 00:00:00 |
Sponsor | SCYNEXIS, Inc.;101 Hudson Street, Suite 3610;Jersey City, New Jersey, 07302 |